Wealthcare Advisory Partners LLC raised its position in UnitedHealth Group Inc (NYSE:UNH) by 24.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 976 shares of the healthcare conglomerate’s stock after acquiring an additional 194 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in UnitedHealth Group were worth $238,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in the business. FMR LLC lifted its stake in UnitedHealth Group by 1.9% in the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after acquiring an additional 1,232,189 shares during the last quarter. Geode Capital Management LLC lifted its stake in UnitedHealth Group by 9.1% in the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after acquiring an additional 965,763 shares during the last quarter. Norges Bank acquired a new stake in UnitedHealth Group in the fourth quarter valued at $2,343,175,000. American Century Companies Inc. lifted its stake in shares of UnitedHealth Group by 12.8% during the 4th quarter. American Century Companies Inc. now owns 5,678,706 shares of the healthcare conglomerate’s stock worth $1,414,679,000 after buying an additional 644,872 shares during the last quarter. Finally, Legal & General Group Plc lifted its stake in shares of UnitedHealth Group by 9.0% during the 4th quarter. Legal & General Group Plc now owns 4,747,709 shares of the healthcare conglomerate’s stock worth $1,182,721,000 after buying an additional 391,437 shares during the last quarter. Hedge funds and other institutional investors own 85.87% of the company’s stock.
NYSE:UNH traded up $1.01 during mid-day trading on Friday, reaching $248.63. 2,322,195 shares of the company’s stock were exchanged, compared to its average volume of 3,650,393. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94. The stock has a market capitalization of $234.66 billion, a price-to-earnings ratio of 19.30, a PEG ratio of 1.32 and a beta of 0.61. The business’s fifty day moving average is $251.66. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $248.00, for a total value of $2,480,000.00. Following the transaction, the director now directly owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the transaction, the director now directly owns 61,309 shares in the company, valued at $15,652,800.79. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 32,000 shares of company stock worth $7,963,620. 0.87% of the stock is owned by insiders.
A number of analysts have recently issued reports on UNH shares. Barclays cut their target price on shares of UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Morgan Stanley raised their target price on shares of UnitedHealth Group from $285.00 to $298.00 and gave the stock an “overweight” rating in a research note on Friday, July 12th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price for the company in a research note on Monday, July 22nd. Royal Bank of Canada set a $311.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, ValuEngine cut shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. One analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $295.06.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: What factors cause inflation to rise?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.